Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus-Naive Infants

A Phase I/II observer-blind, randomized, controlled trial evaluated the safety and immunogenicity of a dengue virus (DENV) vaccine candidate in healthy Thai infants (aged 12–15 months) without measurable pre-vaccination neutralizing antibodies to DENV and Japanese encephalitis virus. Fifty-one subje...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Watanaveeradej, Veerachai, Simasathien, Sriluck, Nisalak, Ananda, Endy, Timothy P., Jarman, Richard G., Innis, Bruce L., Thomas, Stephen J., Gibbons, Robert V., Hengprasert, Sumetha, Samakoses, Rudiwilai, Kerdpanich, Angkool, Vaughn, David W., Putnak, J. Robert, Eckels, Kenneth H., Barrera, Rafael De La, Mammen, Mammen P.
Formato: Artigo
Idioma:Inglês
Publicado: The American Society of Tropical Medicine and Hygiene 2011
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3144835/
https://ncbi.nlm.nih.gov/pubmed/21813857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.2011.10-0501
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares